Phase 3 Ovarian Cancer Trial, Not Yet Recruiting NCT07120815 Sponsor: Helsinki University Central Hospital Condition: Ovarian Cancer
Back to Ovarian Cancer

Phase 3 Ovarian Cancer Trial, Not Yet Recruiting

NCT07120815
Not Yet Recruiting Phase 3

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Polycystic Ovary Syndrome (PCOS), confirmed using the 2023 international PCOS guidelines
  • You are between 18 and 37 years old
  • Your Body Mass Index (BMI) is 25 or above but below 40 (this means you are in the overweight or obese range)
  • You are willing to follow the trial procedures and have signed an agreement to take part
  • You can read and communicate well enough in Finnish or Swedish

Who may not be able to join:

  • You do not have a confirmed PCOS diagnosis based on the 2023 international PCOS guidelines
  • You have used hormonal contraception (such as the pill, patch, or hormonal coil) in the last 3 months
  • You are currently pregnant
  • You are currently breastfeeding
  • You have diabetes that is not being treated
  • You have an underactive thyroid (hypothyroidism)
  • You have higher-than-normal levels of a hormone called prolactin (hyperprolactinemia)
  • You currently take medication for diabetes
  • You currently take medication for high cholesterol
  • You currently take medication for obesity or weight management
  • You currently take cortisone tablets or other oral cortisone-based medication
  • You have had a bad reaction or allergy to a medicine called metformin
  • You have a condition called acute metabolic acidosis, where acid builds up in the body (confirm with trial site)
  • You have kidney problems or reduced kidney function
  • You have liver problems or reduced liver function
  • You have heart failure or serious breathing/lung problems
  • You have a serious mental health condition
  • You have problems with alcohol dependency
  • You work at the clinic running this trial, or are a close family member of someone who does

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 3
Sponsor
Helsinki University Central Hospital
Registry
ClinicalTrials.gov
Start date
1 September 2025
Est. completion
31 December 2027

Where this trial is recruiting

🇫🇮 Finland

Primary endpoints

Weight; Homeostatic model assessment for insulin resistance (HOMA-IR); Hirsutism; Total testosterone; Appearance of severe of adverse effects; Anti-Mullerian hormone (AMH)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov